LP k léčbě plicní arteriální hypertenze (PAH) VII. -Riociguat
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 19933183 | 22. 08. 2022 | ViaPharma s.r.o. | 21 133 200,00 | 19 212 000,00 | 21 133 200,00 | 19 212 000,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| 452_Písemná zpráva.pdf | Písemná zpráva zadavatele | 31. 08. 2022 09:37 | Dokument není zavirovaný |
List of Participants
| Show detail | |||||||
|---|---|---|---|---|---|---|---|
| ViaPharma s.r.o. | Praha | 19 198 908,20 | CZK |
Price Actually Paid in Each Year of Performance
| 19933183 | 2023 | 11 835 530,45 | 10 759 573,14 |
| 19933183 | 2022 | 3 946 878,96 | 3 588 071,78 |